Open Access<p>COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment</p>
Author(s) -
Xinyu Zhu,
Yang Liu,
Kai Huang
Publication year - 2020
Publication title -
diabetes, metabolic syndrome and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s285197
Subject(s) - obesity , medicine , epidemiology , covid-19 , overweight , pandemic , pathogenesis , metabolic syndrome , public health , inflammation , immune system , immunology , disease , pathology , infectious disease (medical specialty)
The growing prevalence of overweight and obesity has been a worldwide public health issue. During the COVID-19 pandemic, obesity is associated with a higher risk of severity and a worse clinical outcome of SARS-COV-2 infection. This may be because of the chronic low-grade inflammation, impaired immune response and metabolic disorders in obese patients. In this narrative review, we have summarized the association between obesity and COVID-19 and discussed the potential pathogenesis and treatment in these patients. This work may provide practical suggestions on the clinical management of obese COVID-19 patients.